Skip to content

Company information lookup

REGENEUS LTD (RGS)

Regenerative medicine.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
RGS 0.300 -3.23% 0.290 0.300 0.310 0.310 0.300 99,000

REGENEUS LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code RGS
Securities
Official Listing Date 19 September, 2013
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.regeneus.com.au
Registered Office Address 77 Ridge Street, GORDON, NSW, AUSTRALIA, 2072
Head Office Telephone (02) 9499 8010
Head Office Fax (02) 9499 8020
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr John Martin (Chairman)
Prof. Graham Vesey (CEO, Director)
Dr Roger Aston (Director)
Prof. Ben Herbert (Director)
Mr Barry Sechos (Director)
Company Secretary Ms Sandra McIntosh
Principal Activities Regenerative medicine.

REGENEUS LTD announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
31/07/2014 asterix Appendix 4C - Q4 FY14 5 PDF
31/07/2014 asterix RGS Product Pipeline Update 4 PDF
08/07/2014   Exclusive global rights for human cancer vaccine-Amended hdr 2 PDF
08/07/2014 asterix Disclosure Document 2 PDF
30/06/2014 asterix RGS enters into agreement for US marketing trial for Kvax 2 PDF
14/05/2014 asterix New treatment option for chronic neuropathic pain patients 3 PDF
17/04/2014 asterix Appendix 4C - quarterly 6 PDF
08/04/2014 asterix Ethics approval for procurement for off-the-shelf treatment 2 PDF
04/04/2014 asterix Regeneus partners with Hennessy Research for Kvax 2 PDF
26/03/2014 asterix HiQCell Joint Registry Results 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
31 Jul 2014 0.310 3.33% 0.310 0.300 119,685
30 Jul 2014 0.300 0% 0.300 0.300 30,000
29 Jul 2014 0.300 0% 0.300 0.295 13,854
28 Jul 2014 0.300 0% 0.300 0.300 3,296
25 Jul 2014 0.300 1.69% 0.300 0.300 49,500

* Volume of shares shown represents only those shares traded on ASX.

REGENEUS LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security RGS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security RGS

Warrants & Structured Products

No warrants & Structured Products are available over the security RGS

ASX CFDs

No Contracts For Differences are available over the security RGS